A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF [mycophenolate mofetil] and Extended Release (XL) [extended-release] Tacrolimus /MMF and Steroid Withdraw in de Novo Liver Transplant Recipients

Trial Profile

A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf (Tacrolimus)/MMF [mycophenolate mofetil] and Extended Release (XL) [extended-release] Tacrolimus /MMF and Steroid Withdraw in de Novo Liver Transplant Recipients

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Sep 2009

At a glance

  • Drugs Mycophenolate mofetil; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 16 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 09 Sep 2009 Actual patient number (48) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top